2018 Life Science Awards Program – Tumor Biology
The future of life science begins with you.
Be recognized for your innovative research in Tumor Biology with the Life Science Award
The 2018 Life Science Award in Tumor Biology will be presented to a graduate student from a U.S., Canadian, Asian Pacific* or European university (excluding Italy) working on transformative advances in the areas of Tumor Biology in life science. The award will recognize exceptional research and advances in cancer applications specifically relating to enhancing the understanding of tumor biology.
Graduate students who have completed or are expected to complete their program between 2017 and 2019 are invited to apply. Finalists will be invited to present their research to company leadership in the fall of 2018. The winner of the award will receive $10,000 and each of the finalists who present their work at the event will be awarded $2,000.
*The list of countries eligible for the award program in 2018 from APAC are: Australia, China, India, Japan, Korea, Singapore, and Taiwan.
Application deadline: August 17, 2018.
How to Apply
Applicants should send the following documents to tbio_award@sial.com by no later than August 17, 2018:
- A curriculum vitae (CV) summarizing education, graduation date, work experience, all publications and external presentations, relevant skills and interests, and leadership activities.
- An application statement (800 words or less, plus graphs/figures) summarizing the context, relevance and impact of the research, key accomplishments, interest in the life science sector, and future plans.
- A 300-word or less abstract for the presentation that will be given if chosen as an award finalist
- A recommendation letter (1-3 pages) from your advisor discussing what makes you stand out and why you should be considered for this award.
Finalists will be announced by September 2018.
Contact for Additional Information: tbio_award@sial.com
Rules and Regulations: Click here
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.